VIKING THERAPEUTICS INC (VKTX:NASDAQ)
$28.51 0.78 (2.8128%)
Analysed VIKING THERAPEUTICS INC (VKTX:NASDAQ) News Sources
Viking Therapeutics Stock Soars 36% on Weight-Loss Drug Data. Why It's Not Too Late to Buy the Stock.
30-09-2026
fool.com
Viking Therapeutics, Inc. (VKTX) Stock Declines While Market Improves: Some Information for Investors
01-10-2026
yahoo.com
Prediction: This Stock Could Double Over the Next 5 Years
02-10-2026
fool.com
Should You Buy Viking Therapeutics Stock While It Trades Below Its $35 Offering Price?
02-10-2026
fool.com
Does Viking Therapeutics (VKTX) Pairing VK2735 Data With Fresh Capital Signal A Sharpened Obesity Strategy?
02-10-2026
yahoo.com
VKTX Down 16% in a Month: Time to Invest or Exit the Stock?
06-10-2026
yahoo.com
Analyst Predicts 316% Upside for Viking Therapeutics Stock Despite 30%+ Loss in Last 3 Months
08-10-2026
tikr.com
Viking Therapeutics, Inc. (VKTX) Dips More Than Broader Market: What You Should Know
08-10-2026
yahoo.com
Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider
09-10-2026
yahoo.com
Viking Therapeutics' Oral Obesity Drug Advances to Phase 3 Testing. Is Now the Time to Buy This Biotech Stock?
10-10-2026
fool.com
What is the current price of VIKING THERAPEUTICS INC (VKTX:NASDAQ)?
The current price of VIKING THERAPEUTICS INC (VKTX:NASDAQ) is $28.51.
VIKING THERAPEUTICS INC (VKTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of VIKING THERAPEUTICS INC (VKTX:NASDAQ) since the previous trading day is $0.78.
VIKING THERAPEUTICS INC (VKTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of VIKING THERAPEUTICS INC (VKTX:NASDAQ) since the previous trading day is 2.8128%.
What is the most recent average sentiment score for VIKING THERAPEUTICS INC (VKTX:NASDAQ)?
The most recent average sentiment score for VIKING THERAPEUTICS INC (VKTX:NASDAQ) is 57 out of 100.
What is the most recent average sentiment for VIKING THERAPEUTICS INC (VKTX:NASDAQ)?
The most recent sentiment for VIKING THERAPEUTICS INC (VKTX:NASDAQ) is .
SEC-8K** Filing Available For VIKING THERAPEUTICS INC (VKTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.